MPMarlies Pasler

Marlies Pasler

*This is an algorithmically generated author record based on publicly available information.

Marlies Pasler has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel methodologies for dosimetry audits: Adapting to advanced radiotherapy techniques

    by Marlies Pasler, Victor Hernandez, Núria Jornet, Catharine H. Clark


  • Error detection capability of a novel transmission detector: a validation study for online VMAT monitoring

    by Marlies Pasler, Kilian Michel, Livia Marrazzo, Michael Obenland, Stefania Pallotta, Mari Bjoernsgard, Johannes Lutterbach

    The purpose of this study was to characterize a new single large-area ionization chamber, the integral quality monitor system (iRT, Germany), for online and real-time beam monitoring. Signal stability, monitor unit (MU) linearity and dose rate dependence were investigated for static and arc deliveries and compared to independent ionization chamber measurements. The dose verification capability of the transmission detector system was evaluated by comparing calculated and measured detector signals for 15 volumetric modulated arc therapy plans. The error detection sensitivity was tested by introducing MLC position and linac output errors. Deviations in dose distributions between the original and error-induced plans were compared in terms of detector signal deviation, dose-volume histogram (DVH) metrics and 2D γ -evaluation (2%/2 mm and 3%/3 mm). The detector signal is linearly dependent on linac output and shows negligible (−1 . Signal stability is within 1% for cumulative detector output; substantial variations were observed for the segment-by-segment signal. Calculated versus measured cumulative signal deviations ranged from −0.16%–2.25%. DVH, mean 2D γ -value and detector signal evaluations showed increasing deviations with regard to the respective reference with growing MLC and dose output errors; good correlation between DVH metrics and detector signal deviation was found (e.g. PTV D mean : R 2 = 0.97). Positional MLC errors of 1 mm and errors in linac output of 2% were identified with the transmission detector system. The extensive tests performed in this investigation show that the new transmission detector provides a stable and sensitive cumulative signal output and is suitable for beam monitoring during patient treatment.


  • Linking log files with dosimetric accuracy – A multi-institutional study on quality assurance of volumetric modulated arc therapy

    by Marlies Pasler, Jochem Kaas, Thijs Perik, Job Geuze, Ralf Dreindl, Thomas Künzler, Frits Wittkamper, Dietmar Georg


  • VMAT techniques for lymph node-positive left sided breast cancer

    by Marlies Pasler, Johannes Lutterbach, Mari Björnsgard, Ursula Reichmann, Susanne Bartelt, Dietmar Georg


  • Node-positive left-sided breast cancer: does VMAT improve treatment plan quality with respect to IMRT?

    by M. Pasler, D. Georg, S. Bartelt, J. Lutterbach

    The aim of the present work was to explore plan quality and dosimetric accuracy of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for lymph node-positive left-sided breast cancer. VMAT and IMRT plans were generated with the Pinnacle3 V9.0 treatment planning system for 10 lymph node-positive left-sided breast cancer patients. VMAT plans were created using a single arc and IMRT was performed with 4 beams using 6, 10, and 15 MV photon energy, respectively. Plans were evaluated both manually and automatically using ArtiView™. Dosimetric plan verification was performed with a 2D ionization chamber array placed in a full scatter phantom. Photon energy had no significant influence on plan quality for both VMAT and IMRT. Large variability in low doses to the heart was found due to patient anatomy (range V5 Gy 26.5–95 %). Slightly more normal tissue dose was found for VMAT (e.g., VTissue30% = 22 %) than in IMRT (VTissue30% = 18 %). The manual and ArtiView™ plan evaluation coincided very accurately for most dose metrics (difference < 1 %). In VMAT, 96.7 % of detector points passed the 3 %/3 mm gamma criterion; marginally better accuracy was found in IMRT (98.3 %). VMAT for node-positive left-sided breast cancer retains target homogeneity and coverage when compared to IMRT and allows maximum doses to organs at risk to be reduced. ArtiView™ enables fast and accurate plan evaluation. Ziel der Studie war die Evaluierung der Planqualität und der dosimetrischen Genauigkeit von intensitätsmodulierter Strahlentherapie (IMRT) und volumetrisch modulierter Rotationstherapie (VMAT) für Patientinnen mit lymphknotenpositivem linksseitigem Mammakarzinom. VMAT- und IMRT-Pläne wurden mit dem Pinnacle3-Bestrahlungsplanungssystem (V9.0) für 10 Patientinnen mit lymphknotenpositivem linksseitigem Mammakarzinom generiert. VMAT-Pläne wurden mit einer Rotation, IMRT-Pläne mit 4 Feldern mit jeweils 6, 10 und 15 MV erstellt. Die Planauswertung erfolgte sowohl manuell als auch automatisch mittels ArtiView™. Die Planverifikation wurde mit einer 2-D-Ionisationskammer-Matrix in einem Festkörperphantom durchgeführt. Die Photonenenergie hat keinen signifikanten Einfluss auf die VMAT- und IMRT-Planqualität. Es wurden aufgrund unterschiedlicher Anatomien große Variationen im Niedrigdosisvolumen des Herzens festgestellt (V5 Gy 26,5–95 %). In VMAT-Plänen wurde ein geringfügig höheres Niedrigdosisvolumen (z. B. VTissue30% = 22 %) als in IMRT-Plänen (VTissue30% = 18 %) ermittelt. Manuelle und automatische Auswertung stimmten für die meisten Parameter sehr genau überein (Abweichung < 1 %). VMAT-Pläne erreichten einen Gamma-Index < 1 (3 mm Abstand und 3 % Dosis) für 96,7 % der Detektorpunkte, geringfügig bessere Präzision erzielten die IMRT-Pläne mit 98,3 %. VMAT liefert eine ähnliche Dosishomogenität und -abdeckung der Zielvolumina wie IMRT und ermöglicht eine Reduktion der Risikoorgan- und Maximaldosen. Mittels ArtiView™ können Bestrahlungspläne schnell und genau evaluiert werden.


  • Impact of Gantry Rotation Time on Plan Quality and Dosimetric Verification – Volumetric Modulated Arc Therapy (VMAT) vs. Intensity Modulated Radiotherapy (IMRT)

    by Marlies Pasler, Holger Wirtz, Johannes Lutterbach

    To compare plan quality criteria and dosimetric accuracy of step-and-shoot intensity-modulated radiotherapy (ss-IMRT) and volumetric modulated arc radiotherapy (VMAT) using two different gantry rotation times. This retrospective planning study based on 20 patients was comprised of 10 prostate cancer (PC) and 10 head and neck (HN) cancer cases. Each plan contained two target volumes: a primary planning target volume (PTV) and a boost volume. For each patient, one ss-IMRT plan and two VMAT plans at 90 s (VMAT90) and 120 s (VMAT120) per arc were generated with the Pinnacle© planning system. Two arcs were provided for the PTV plans and a single arc for boost volumes. Dosimetric verification of the plans was performed using a 2D ionization chamber array placed in a full scatter phantom. VMAT reduced delivery time and monitor units for both treatment sites compared to IMRT. VMAT120 vs. VMAT90 increased delivery time and monitor units in PC plans without improving plan quality. For HN cases, VMAT120 provided comparable organs at risk sparing and better target coverage and conformity than VMAT90. In the VMAT plan verification, an average of 97.1% of the detector points passed the 3 mm, 3% γ criterion, while in IMRT verification it was 98.8%. VMAT90, VMAT120, and IMRT achieved comparable treatment plans. Slower gantry movement in VMAT120 plans only improves dosimetric quality for highly complex targets.